L-arginine is a nutritionally dispensable amino acid, which is involved in many physiologic processes including nitric oxide (NO) synthesis. The L-arginine/NO pathway is a part of the normal process of cardiovascular autoregulation and it is probably deficient in patients with essential hypertension. L-arginine supplement prevent the induction of hypertension in rat-sensitive models and produce hypotension in healthy humans when given intravenously. The benefit of L-arginine supplementation has not clearly been demonstrated in humans with essential hypertension. This study will explore the in vivo adaptation mechanisms involved in arginine metabolism and homeostasis and in whole body nitric oxide production (measured as NO excretion) in such patients. We will also correlate metabolic data with a complete and exhaustive clinical evaluation. Ten patients will receive a controlled diet with a normal L-arginine intake (56.1 mg/Kg/day) and then an arginine-supplemented (561 mg/Kg/day) isonitrogenous diet. Clinical outcome measures include daily blood pressure, as well as catecholamines, hANP, AVP, aldosterone, cGMP level and renin activity on day one and day seven of each diet period. At the end of each diet period, an 8h stable-isotopic labelled tracer study will be performed to evaluate the arginine, ornithine and urea fluxes as well s the NO production via measurement of nitrite/nitrate. This project will shed new light on the potential benefit of arginine supplement in diseases involving the L-arginine/NO pathway, such as essential hypertension. It will also define more completely the metabolic basis underlying body arginine homeostasis in human adults.
Bennett, Susan E; Schmitt, William P; Stanford, Fatima C et al. (2018) Case 22-2018: A 64-Year-Old Man with Progressive Leg Weakness, Recurrent Falls, and Anemia. N Engl J Med 379:282-289 |
Raphael, Bram P; Jorina, Maria; Gallotto, Mary et al. (2018) Innovative Discharge Process for Families with Pediatric Short Bowel Syndrome: A Prospective Nonrandomized Trial. JPEN J Parenter Enteral Nutr 42:1295-1303 |
Xu, Shuying; Feliu, Marianela; Lord, Allison K et al. (2018) Biguanides enhance antifungal activity against Candida glabrata. Virulence 9:1150-1162 |
Ferrer, Christina M; Alders, Marielle; Postma, Alex V et al. (2018) An inactivating mutation in the histone deacetylase SIRT6 causes human perinatal lethality. Genes Dev 32:373-388 |
Bos, Stijn A; Gill, Corey M; Martinez-Salazar, Edgar L et al. (2018) Preliminary investigation of brown adipose tissue assessed by PET/CT and cancer activity. Skeletal Radiol : |
Palad, Carl J; Stanford, Fatima Cody (2018) Use of people-first language with regard to obesity. Am J Clin Nutr 108:201-203 |
Murphy, Caitlin A; Fitch, Kathleen V; Feldpausch, Meghan et al. (2018) Excessive Adiposity and Metabolic Dysfunction Relate to Reduced Natriuretic Peptide During RAAS Activation in HIV. J Clin Endocrinol Metab 103:1558-1565 |
Slatko, Barton E; Gardner, Andrew F; Ausubel, Frederick M (2018) Overview of Next-Generation Sequencing Technologies. Curr Protoc Mol Biol 122:e59 |
Gomez, G; Stanford, F C (2018) US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity. Int J Obes (Lond) 42:495-500 |
deFilippi, Christopher; Christenson, Robert; Joyce, Jessica et al. (2018) Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV. J Acquir Immune Defic Syndr 78:105-110 |
Showing the most recent 10 out of 1081 publications